Specify a stock or a cryptocurrency in the search bar to get a summary
AEON Biopharma, Inc.
AEONAEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine, as well as develops ABP-450 for the treatment of gastroparesis and posttraumatic stress disorder. The company is based in Irvine, California. Address: 5 Park Plaza, Irvine, CA, United States, 92614
Analytics
WallStreet Target Price
5 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures AEON
Dividend Analytics AEON
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History AEON
Stock Valuation AEON
Financials AEON
Results | 2019 | Dynamics |